4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-19-049320
Options or other derivatives
- Chief Business Officer acquired 10,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Klein Lawrence Otto Chief Business Officer | 2019-09-10 | Grant or award · Restricted Stock Units | +10,000 | 30,000 | D | ||
Loading xslF345X03/doc4.xml…